Literature DB >> 3488859

Inhibition of complement activation by IgG4 antibodies.

J S van der Zee, P van Swieten, R C Aalberse.   

Abstract

Prolonged exposure to antigens may result in high IgG4 antibody titres as was shown in a previous paper (Aalberse et al., 1983b). In novice bee keepers, a shift in the IgG1/IgG4 ratio of the response against phospholipase-A (PLA; a major component of bee venom) occurred. This resulted in an IgG4-dominated response after approximately 2 years of bee-keeping experience. Subject of the present study was the influence of relatively high concentrations of IgG4 antibodies on the biological activity of immune complexes. In the PLA antigen model, it was demonstrated that IgG4-containing immune complexes do not activate complement and that IgG4 antibodies effectively inhibit immune precipitation and complement activation by IgG1 antibodies. Evidence is provided that IgG4 antibodies inhibit binding of C1q to IgG1 in mixed, IgG1- and IgG4-containing complexes. It is proposed that IgG4 antibodies protect against the biological effects of the complement-fixing IgG subclasses. For this reason, determination of the total IgG response or just determination of antibody activity in the complement-fixing isotypes is insufficient in immune-complex diseases. The modulating effect of the non-complement-fixing isotypes should be taken into account to predict the biological activity of the immune complexes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488859      PMCID: PMC1542347     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Non-precipitating antibodies isolated by immunoadsorption.

Authors:  R A Margni; M E Cordal; J Leoni; S E Hajos; S Veira; M Manghi; M Bazzurro
Journal:  Immunochemistry       Date:  1977-04

2.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

3.  Purification and properties of non-precipitating rabbit antibodies.

Authors:  R Margni; R Binaghi
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

4.  Gene deletion and gene duplication within the cluster of human heavy-chain genes. Selective absence of IgG sub-classes.

Authors:  E van Loghem; R I Sukernik; L P Osipova; B J Zegers; H Matsumoto; G de Lange; G Lefranc
Journal:  J Immunogenet       Date:  1980-08

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  The production of precipitating antiglobulin reagents specific for the subclasses of human IgG.

Authors:  M van der Giessen; B de Lange; B van der Lee
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

7.  Purification and radiolabeling of human C1q.

Authors:  A J Tenner; P H Lesavre; N R Cooper
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

8.  The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.

Authors:  D E Isenman; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

9.  IgG4 and passive sensitization of basophil leukocytes.

Authors:  A W van Toorenenbergen; R C Aalberse
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

10.  An inhibition method utilizing the laser nephelometer to measure human specific "blocking antibodies".

Authors:  L E Mansfield; R Le Dieux; J Lima; G S Brown
Journal:  Ann Allergy       Date:  1980-10
View more
  77 in total

1.  Serum IgG subclass antibodies to a variety of food antigens in patients with coeliac disease.

Authors:  M Hvatum; H Scott; P Brandtzaeg
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 2.  Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

3.  IgG subclass-containing cells in the human large bowel of normal controls, non-IBD colitis, and ulcerative colitis.

Authors:  M Iizuka
Journal:  Gastroenterol Jpn       Date:  1990-02

4.  Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites.

Authors:  J Schuurman; R Van Ree; G J Perdok; H R Van Doorn; K Y Tan; R C Aalberse
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

5.  Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.

Authors:  Seth Sweetser; David A Ahlquist; Neal K Osborn; Schuyler O Sanderson; Thomas C Smyrk; Suresh T Chari; Lisa A Boardman
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

6.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

Review 7.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

8.  Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed.

Authors:  J E Persselin; R H Stevens
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  Functional properties of nonhuman primate antibody to Porphyromonas gingivalis.

Authors:  D M Anderson; J L Ebersole; M J Novak
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 10.  IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.

Authors:  Maartje G Huijbers; Jaap J Plomp; Silvère M van der Maarel; Jan J Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.